LATISSE - 0023-3616-81 - (bimatoprost)

Alphabetical Index


Drug Information of LATISSE

Product NDC: 0023-3616
Proprietary Name: LATISSE
Non Proprietary Name: bimatoprost
Active Ingredient(s): .3    mg/mL & nbsp;   bimatoprost
Administration Route(s): OPHTHALMIC
Dosage Form(s): SOLUTION/ DROPS
Coding System: National Drug Codes(NDC)

Labeler Information of LATISSE

Product NDC: 0023-3616
Labeler Name: Allergan, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022369
Marketing Category: NDA
Start Marketing Date: 20090126

Package Information of LATISSE

Package NDC: 0023-3616-81
Package Description: 1 BOTTLE, DROPPER in 1 CARTON (0023-3616-81) > 3 mL in 1 BOTTLE, DROPPER

NDC Information of LATISSE

NDC Code 0023-3616-81
Proprietary Name LATISSE
Package Description 1 BOTTLE, DROPPER in 1 CARTON (0023-3616-81) > 3 mL in 1 BOTTLE, DROPPER
Product NDC 0023-3616
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name bimatoprost
Dosage Form Name SOLUTION/ DROPS
Route Name OPHTHALMIC
Start Marketing Date 20090126
Marketing Category Name NDA
Labeler Name Allergan, Inc.
Substance Name BIMATOPROST
Strength Number .3
Strength Unit mg/mL
Pharmaceutical Classes Prostaglandin Analog [EPC],Prostaglandins [Chemical/Ingredient]

Complete Information of LATISSE


General Information